You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 117 No. 1, January 1969 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Hyperornithinemia, Hyperammonemia, and Homocitrullinuria

A New Disorder of Amino Acid Metabolism Associated With Myoclonic Seizures and Mental Retardation

Vivian E. Shih, MD; Mary L. Efron, MD; Hugo W. Moser, MD

Am J Dis Child. 1969;117(1):83-92.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

THE Krebs-Henseleit urea cycle is the only biochemical pathway for the conversion of ammonia to urea in man (Fig 1). It is known to involve five enzymatic reactions and, so far, four genetically determined disease states have been described, each of which is characterized by a deficiency of one of the urea cycle enzymes.1 All of these states are associated with varying degrees of hyperammonemia which, as would be expected, are most severe in the disorders of steps 1 and 2, and least severe in argininosuccinic aciduria where it usually occurs only after a protein load. The clinical picture of all these disorders includes a reluctance to eat high protein foods, intermittent ataxia, irritability, lethargy or even coma, and mental retardation. There are several instances in which a low protein diet simultaneously caused clinical improvement and reduction or elimination of hyperammonemia. For this and other reasons, it is likely . . . [Full Text PDF of this Article]


Author Affiliations

Boston

From the Department of Neurology, Harvard Medical School, and the Joseph P. Kennedy, Jr. Memorial Laboratories, Massachusetts General Hospital, Boston.


Footnotes

Received for publication May 22, 1968.

Doctor Efron died on Sept 2, 1967.

Submitted by the authors for the Mary Efron Memorial Issue of the JOURNAL.

Reprint requests to Massachusetts General Hospital, Fruit Street, Boston 02114 (Dr. Shih).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1969 American Medical Association. All Rights Reserved.